Position in CRL
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$133,396,837
+$77,340,165 QoQ
Shares Held
773,315
+175.2% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Amundi holds $3,077,327,149 across 24 Diagnostics & Research names. CRL ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,016,260 | $991,052,273 | |
| 2 | DHR |
Danaher Corp /De/
|
2,611,092 | $495,063,039 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
610,779 | $343,190,609 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
171,020 | $215,690,423 | |
| 5 | QGEN |
Qiagen N.V.
|
4,757,681 | $190,497,545 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
869,003 | $148,199,770 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
This page
|
773,315 | $133,396,837 | |
| 8 | WAT |
Waters Corp /De/
|
432,146 | $128,693,078 |
All Filings in CRL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $133,396,837 | 773,315 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $56,056,672 | 281,014 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $48,529,824 | 310,174 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $34,329,974 | 226,257 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,460,549 | 16,347 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,971,102 | 70,266 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $10,570,785 | 53,667 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $12,045,677 | 58,310 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,634,353 | 57,702 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,687,473 | 70,590 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,759,127 | 44,694 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,136,577 | 67,237 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $35,603,063 | 176,410 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $24,497,841 | 112,427 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,193,820 | 138,180 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $41,361,038 | 193,303 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $40,953,297 | 144,217 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $52,486,202 | 139,302 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $78,716,801 | 190,750 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $57,584,700 | 155,668 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||